Centers & Cores

The Department of Nanomedicine focuses on conducting interdisciplinary research to combine nanoengineering, mathematical modeling and biomedical sciences to develop nanotechnology-enabled therapeutic and diagnostic platforms for combating diseases including cancer, cardiovascular diseases and infectious diseases. Several centers and cores support the research work in the Department of Nanomedicine. 

Peptidomics Nanoengineering Core

The Peptidomics Nanoengineering Core designs and fabricates NanoTraps for protein/peptide biomarker discovery. This active research laboratory continuously develops new methods to improve results. Our service provides customized NanoTraps for specific biomarker detection.

Nanoengineering Core 

The Nanoengineering Core develops and provides silicon-based nanotechnology to support innovative biomedical research. By taking advantage of industrial silicon microfabrication techniques, the core creates novel nanomaterials and nanodevices for biomedical applications. Through a combination of microfabrication and chemistry, a series of fabrication protocols have been developed to make various porous silicon particles for multistage delivery systems.

Biomicrofluidics Core

Biomicrofluidics Core at Houston Methodist creates custom designed microfluidic molds and chips, fabricates pre-made biomicrofluidic chips and provides consultation services for biomicrofluidics projects. Some of the pre-made chips include the V- and M-chips and chips that perform single-cell analysis and cell separation.

Physical Sciences-Oncology Center (PSOC) 

The Physical Sciences-Oncology Center (PSOC) strives to understand the physics of mass transport within a cancer lesion and mass exchanges between cancer and surrounding biological host with a deeper understanding of the differentials in transport properties to uncover the evolution of malignancies. The overall goal, through the understanding of the mechanism, is to develop and improve cancer diagnosis and treatment. The PSOC will focus on two specific cancer types: colorectal cancer, the second leading cause of cancer death in the United States, and liver metastasis, the most common site of metastatic disease.